ANI Pharmaceuticals Balance Sheet
NASDAQ: ANIPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ANI Pharmaceuticals financial position
At the end of fiscal 2025, ANI Pharmaceuticals reported total assets of $1.44 billion, up 12.1% from a year earlier against total liabilities of $899.7 million. Shareholders' equity stood at $540.7 million, or 37.5% of assets. The company held $285.6 million in cash and equivalents against $309.1 million of debt, a net debt position of $23.5 million.
The current ratio (current assets divided by current liabilities) was 2.71, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.57.
Summary generated from market data by MetaCap's automated system. Methodology
ANI Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 285.58M | 144.89M | 221.12M | 48.23M | 100.30M | 7.86M | 62.33M | 43.01M | 31.14M | 27.36M |
| Receivables | 281.08M | 221.73M | 162.08M | 165.44M | 128.53M | 95.79M | 72.13M | 64.84M | 58.79M | 45.90M |
| Inventory | 143.07M | 136.78M | 111.20M | 105.36M | 81.69M | 60.80M | 48.16M | 40.50M | 37.73M | 26.18M |
| Total Current Assets | 753.12M | 528.46M | 519.82M | 344.26M | 321.77M | 170.32M | 187.69M | 152.88M | 131.60M | 103.01M |
| Property, Plant & Equipment | 62.48M | 56.86M | 44.59M | 43.25M | 52.67M | 41.27M | 40.55M | 38.09M | 20.40M | 11.00M |
| Goodwill | 62.48M | 59.99M | 28.22M | 28.22M | 27.89M | 3.58M | 3.58M | 3.58M | 1.84M | 1.84M |
| Intangible Assets | 479.53M | 541.83M | 209.01M | 251.63M | 294.12M | 188.51M | 180.39M | 201.60M | 229.79M | 175.79M |
| Total Assets | 1.44B | 1.28B | 904.42M | 760.09M | 771.60M | 461.19M | 456.79M | 430.60M | 412.14M | 322.86M |
| Accounts Payable | 62.58M | 45.66M | 36.68M | 29.30M | 22.97M | 11.26M | 14.61M | 8.88M | 3.63M | 3.39M |
| Short-Term Debt | 17.27M | 9.17M | 850.00K | 850.00K | 850.00K | 13.24M | 9.94M | 3.26M | 3.35M | 0 |
| Total Current Liabilities | 278.11M | 194.45M | 145.48M | 99.44M | 87.54M | 78.56M | 61.68M | 165.55M | 39.23M | 31.95M |
| Long-Term Debt | 291.84M | 309.11M | 284.82M | 285.67M | 286.52M | 172.44M | 175.81M | 67.30M | 69.95M | 0 |
| Total Liabilities | 899.65M | 855.94M | 446.82M | 421.55M | 412.86M | 265.49M | 244.00M | 233.34M | 237.38M | 153.22M |
| Shareholders' Equity | 540.72M | 403.68M | 432.75M | 313.69M | 333.89M | 195.70M | 212.79M | 197.26M | 174.76M | 169.65M |
| Retained Earnings | -23.10M | -100.28M | -80.13M | -97.29M | -47.77M | -4.97M | 17.58M | 11.49M | -4.01M | -2.92M |
| Total Debt | 309.11M | 318.28M | 285.67M | 286.52M | 287.37M | 185.69M | 185.75M | 70.55M | 73.30M | 0 |
| Net Cash (Debt) | -23.52M | -173.39M | -64.55M | -238.29M | -187.07M | -177.82M | -123.42M | -27.54M | -42.16M | 27.36M |
| Shares Outstanding | 22.49M | 21.11M | — | — | — | — | — | — | — | — |
This table shows 10 annual periods of ANI Pharmaceuticals's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow ANIP's reporting calendar. What is a balance sheet?